Is Relaxin-2 legal in Australia?

The pregnancy hormone that opens the circulation. A 1,161 patient phase 3 trial reported 42 deaths against 65 on placebo at 180 days as an additional endpoint, and the 6,545 patient confirmatory trial found cardiovascular death of 8.7 percent against 8.9 percent, hazard ratio 0.98. Serelaxin was never approved and development for acute heart failure stopped.

Relaxin-2 is a two-chain peptide hormone of the insulin superfamily, made by the corpus luteum and the placenta, and it is the reason a pregnant woman's cardiac output rises and her blood vessels and kidneys relax. That physiology is not in question and it is a perfectly good reason to have wondered whether the same hormone could help a failing heart.

Mechanism: Relaxin-2 acts at RXFP1, a G protein-coupled receptor, and produces systemic vasodilation, increased cardiac output, increased renal blood flow and increased arterial compliance, largely through nitric oxide and cyclic AMP dependent pathways, together with anti-fibrotic signalling that has been the focus of most later work. It is a two-chain molecule held together by disulfide bonds, built like insulin, which is why it is hard and expensive to manufacture and why simplified single-chain analogues were designed.

Regulatory history: Relaxin-2 is an endogenous hormone. Serelaxin, its recombinant form, is not approved by the FDA or any other regulator. It received attention after the RELAX-AHF result but the confirmatory RELAX-AHF-2 trial failed both primary endpoints and development for acute heart failure was discontinued.

Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.

The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for Relaxin-2 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.